SCHEMBL6172002

SCHEMBL6172002

CC(c1ccncc1C(=O)Oc1ccccc1)C1NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
IGF1R P08069 2/20 0.34
RXFP1 Q9HBX9 2/20 0.32
KMT2A Q03164 1/20 0.31
ALDH1A1 P00352 1/20 0.31
PTGS1 P23219 1/20 0.30
PTGS2 P35354 1/20 0.30
MAPT P10636 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173353 0.88 LMNA (0.45) LMNAKMT2AALDH1A1
SCHEMBL6174658 0.87 RXFP1 (0.34) LMNAIGF1RRXFP1ALDH1A1MAPT
SCHEMBL6170251 0.83 IGF1R (0.33) LMNAIGF1R
SCHEMBL6172898 0.83 SLC6A9 (0.38) LMNAKMT2AALDH1A1
SCHEMBL6175297 0.82 LMNA (0.39) LMNAIGF1RPTGS2
SCHEMBL6175175 0.82 IGF1R (0.36) LMNAIGF1RPTGS2
SCHEMBL6171994 0.81 ALDH1A1 (0.37) LMNAIGF1RRXFP1KMT2AALDH1A1
SCHEMBL6175990 0.80 KIF11 (0.37) LMNAIGF1RRXFP1
SCHEMBL6171408 0.80 IGF1R (0.35) LMNAIGF1RPTGS2
SCHEMBL6174450 0.80 IGF1R (0.38) LMNAIGF1RRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed